Pathologic features of antibody-mediated rejection in renal allografts: An expanding spectrum

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 3, 2012, Pages 264-271

  Haas, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

antibody mediated rejection; C4d; protocol biopsy; renal transplantation; transplant glomerulopathy

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D;

ANTIBODY MEDIATED REJECTION; ANTIBODY SPECIFICITY; ARTERIAL INTIMAL FIBROSIS; ARTERITIS; BIOPSY; BLOOD VESSEL INJURY; CLINICAL FEATURE; FIBROSIS; GLOMERULOPATHY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; KIDNEY ALLOGRAFT; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; ARTERITIS; BIOPSY; COMPLEMENT C4B; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; PEPTIDE FRAGMENTS; RENAL ARTERY; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 84859636618     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283520efa     Document Type: Review

References (51)

1. Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008; 86:377-383.
2. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18:1046-1056. (Pubitemid 46536891)
3. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10:464-471.
4. Halloran PF, Wadgymar A, Ritchie S, et al. The significance of the anticlass I antibody response. I: Clinical and pathologic features of anticlass I-mediated rejection. Transplantation 1990; 49:85-91.
5. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anticlass I antibody response. II: Clinical and pathologic features of renal transplants with anticlass I-like antibody. Transplantation 1992; 53:550-555.
6. Trpkov K, Campbell P, Pazderka F, et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody: analysis using the Banff grading schema. Transplantation 1996; 61:1586-1592. (Pubitemid 26190900)
7. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63:1888-1893. (Pubitemid 36513338)
8. Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10:1517-1523. A concise review discussing the pathology, pathogenesis, and treatment of de-novo and recurrent TMA in renal allografts.
9. Randhawa PS, Shapiro R, Jordan ML, et al. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol 1993; 17:60-68. (Pubitemid 23011321)
10. Trimarchi HM, Truong LD, Brennan S, et al. FK506-associated thrombotic microangiopathy. Transplantation 1999; 67:539-544.
11. Meehan SM, Baliga R, Poduval R, et al. Platelet CD61 expression in vascular calcineurin inhibitor toxicity of renal allografts. Hum Pathol 2008; 39:550-556.
12. Satoskar AA, Pelletier R, Adams P, et al. De novo thrombotic microangiopathy in renal allograft biopsies: role of antibody-mediated rejection. Am J Transplant 2010; 10:1804-1811. A study of over 900 renal allograft biopsies from 2003 to 2008, 6% of which showed de-novo TMA. Although only 25% of the total biopsies were C4d-positive, 55% of biopsies with TMA were C4d-positive, suggesting that AMR is the most common cause of de-novo TMA in renal allografts.
13. Meehan SM, Kremer J, Ali FN, et al. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies. Clin J Am Soc Nephrol 2011; 6:395-403. This study showed TMA in 12% of C4d-positive renal allograft biopsies done within 90 days of transplantation, and that the combination of C4d and TMA was associated with a high rate of graft loss.
14. Feucht HE, Felber E, Gokel MJ, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86:464-470.
15. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10:2208-2214. (Pubitemid 29453499)
16. Regele H, Exner M, Watschinger B, et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001; 16:2058-2066. (Pubitemid 32970570)
17. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation. II: Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13:779-787. (Pubitemid 34183946)
18. Bohmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13:1091-1099. (Pubitemid 34274108)
19. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002; 13:234-241. (Pubitemid 34042033)
20. Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13:242-251. (Pubitemid 34042034)
21. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12:574-582. (Pubitemid 32180027)
22. Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13:2371-2380. (Pubitemid 34925248)
23. Zwirner J, Felber E, Herzog V, et al. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int 1989; 36:1069-1077. (Pubitemid 20049214)
24. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria: an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3:708-714. (Pubitemid 36745243)
25. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibodymediated rejection in solid organ transplantation. Am J Transplant 2004; 4:1033-1041. (Pubitemid 38868592)
26. Rush D, Nickerson P, Gough J, et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9:2129-2134. (Pubitemid 28482163)
27. Nickerson P, Jeffery J, Gough J, et al. Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study. J Am Soc Nephrol 1999; 10:1801-1805. (Pubitemid 29364680)
28. Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibodymediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7:576-585. (Pubitemid 46376440)
29. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9:2561-2570.
30. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8:753-760. (Pubitemid 351347767)
31. Mengel M, Bogers J, Bosmans J-L, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5:1050-1056. (Pubitemid 40571253)
32. Stegall MD, Park WD, Larson TS, et al. The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant 2011; 11:698-707. A large study of protocol biopsies of conventional renal allografts taken 1 and 5 years after transplantation, in the era of modern immunosuppression. Among 343 patients undergoing a biopsy at 5 years, only 8% had transplant glomerulopathy and fewer than 20% had moderate or severe tubular atrophy, interstitial fibrosis, and arterial intimal fibrosis.
33. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody- mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7:1743-1752. (Pubitemid 46905427)
34. Baid-Agrawal S, Farris AB III, Pascual M, et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 2011; 80:878-885. This is a study of causes of transplant glomerulopathy in 25 biopsies with transplant glomerulopathy identified in a series of 209 consecutive renal allograft biopsies performed for chronic graft dysfunction. Three partially overlapping causes accounted for 21 of the 25 cases of transplant glomerulopathy: antibody- mediated graft injury (C4d-positive), hepatitis C, and TMA. The findings are important, as they identify causes of transplant glomerulopathy other than alloantibody.
35. Wavamunno MD, O'Connell PJ, Vitalone M, et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007; 7:1-12.
36. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7:2124-2132. (Pubitemid 47247042)
37. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9:2312-2323.
38. Hidalgo LG, Sis B, Sellares J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010; 10:1812-1822. A study of 145 renal allograft biopsies done for cause, in which microarray analysis was used to identify a set of 23 DSA-specific gene transcripts. Seven of these transcripts show high expression in NK cells, and the authors also used immuno-histochemistry to demonstrate prominent numbers of NK cells within peritubular capillaries in biopsies with antibody-mediated, but not cell-mediated, rejection.
39. Anegon I, Cuturi MC, Trinchieri G, Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin-2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988; 167:452-472. (Pubitemid 18073647)
40. Haas M, Mirocha J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 2011; 11:2123-2131. A study of 98 early (<3 months after transplantation), for cause renal allograft biopsies that were examined by electron microscopy. Fifty to 60% of the biopsies with C4d-positive or C4d-negative AMR showed each of three early changes of endothelial injury in glomeruli by electron microscopy, compared with 0% of biopsies showing CMR or no rejection. Among 18 DSA-positive patients showing these early changes, progression to overt transplant glomerulopathy was seen in two of eight patients who were treated for AMR after the early biopsy and six of eight who were not; seven of the latter eight patients had C4d-negative AMR.
41. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713-723. (Pubitemid 29082898)
42. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human allografts. Transplantation 1983; 35:458-463. (Pubitemid 13089917)
43. Kolbeck PC, Tatum AH, Sanfilippo F. Relationships among the histologic pattern, intensity, and phenotypes of T cells infiltrating renal allografts. Transplantation 1984; 38:709-713. (Pubitemid 15183485)
44. Einecke G, Melk A, Ramassar V, et al. Expression of CTL associated transcripts precedes the development of tubulitis in T cell mediated kidney graft rejection. Am J Transplant 2005; 5:1827-1836. (Pubitemid 41039855)
45. Kozakowski N, Bohmig GA, Exner M, et al. Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome. Nephrol Dial Transplant 2009; 24:1979-1986.
46. Messias NC, Eustace JA, Zachary AA, et al. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001; 72:655-660. (Pubitemid 32802748)
47. Lefaucheur C, Nochy D, Hill GS, et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7:832-841. (Pubitemid 46481179)
48. Minervini MI, Torbenson M, Scantlebury V, et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). Am J Surg Pathol 2000; 24:553-558. (Pubitemid 30180748)
49. Haas M, Kraus ES, Samaniego-Picota M, et al. Acute renal allograft rejection with intimal arteritis: histologic predictors of response to therapy and graft survival. Kidney Int 2002; 61:1516-1526. (Pubitemid 34304514)
50. Hill GS,Nochy D, Bruneval P, et al. Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol 2011; 22:975-983. A study of 3-month and 12-month protocol biopsies of renal allografts in 40 patients with DSAs and 59 without, excluding patients with arteritis. The authors demonstrated a significantly higher rate of progression of arterial intimal fibrosis in the DSA-positive cohort. Furthermore, although the intimal fibrosis in the majority of DSA-positive patients showed a hypercellular zone close to the endothelium, there were DSA-positive patients with a prior history of acute AMR whose biopsies showed bland intimal fibrosis, indistinguishable from banal arteriosclerosis.
51. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44:411-422. (Pubitemid 23228698)